logo
How safe are ‘natural' Ozempic alternatives in diabetes care?

How safe are ‘natural' Ozempic alternatives in diabetes care?

India Today2 days ago
It was late evening when Meera Rao sat at her kitchen table, surrounded by brightly coloured bottles—some labeled 'saffron blend', others 'organic GLP1 support'. The glossy covers promised safer, natural alternatives to GLP1 (glucagon-like peptide-1) drugs such as Ozempic, touting appetite control, gentle bloodsugar regulation and zero side-effects.But Rao, a 45-year-old homemaker in Noida, who had been recently diagnosed with prediabetes, felt overwhelmed. Should she trust a prescription GLP1 receptor agonist or experiment with a 'natural' dose?advertisementGLP1 is a gutderived hormone that enhances insulin secretion, curbs hunger and slows down digestion. Synthetic GLP1 receptor agonists—semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro)—have revolutionised diabetes and weightloss treatment.Ozempic can induce up to 15–20 per cent bodyweight reduction while Mounjaro's launch in India has seen a sales surge, doubling in July 2025 alone to total over Rs 470 crore for 157,000 units sold.
Unsurprisingly, India's GLP1 market, valued at about $106 million in 2023, is projected to expand nearly sixfold to $579 million by 2030. And India's broader diabetes care drugs market, ranging between $1.70 billion and $2.27 billion as of 2024-25, is expected to reach $2 billion-$ 3.7 billion by 2030. With over 74 million Indians already living with diabetes, projected to climb even higher in coming decades, the demand is real.Yet, the high cost and limited access to GLP1 injections drive a parallel boom: the rise of 'natural substitutes'. Products using naturally-derived ingredients are now being marketed to support GLP1 and GIP hormone pathways. With a polished label, 'natural' guarantee, a moneyback promise and five-star reviews, it lures hopeful consumers towards wellness narratives. Brand labels draped in pastel tones, slogans whispering 'organic, plantbased, gentle', and lifestyle images of yoga mats and herbal teas—all designed to feel less pharmaceutical and more holistic.A wave of 'gut-first' supplements are also being marketed as natural GLP-1 alternatives, aiming to mimic the hormone's appetite-suppressing and glucose-regulating effects. These products often combine ingredients like prebiotic fibers (inulin, psyllium), apple cider vinegar, cinnamon, berberine and probiotics to promote satiety, balance blood sugar and support insulin sensitivity.Saffron, touted for mood and craving control, and glucomannan, a water-soluble fibre, are also being added to blends that promise to stimulate natural gut hormone responses. While the science behind gut health's role in metabolic regulation is evolving, most of these formulations lack the robust clinical data that GLP-1 drugs like Ozempic have, making them more supportive than substitutive in managing weight or diabetes.Some substitutes, such as BRP, a natural peptide-based alternative to GLP1 drugs, are being researched upon as alternatives with less side-effects. Identified by researchers at Stanford via an AI-driven tool that sifted through thousands of potential hormone fragments, this peptide is taken from the BRINP2 protein through natural processing, and has been detected in biological samples including human cerebrospinal fluid.advertisementIn preclinical studies involving mice and mini pigs, BRP significantly suppressed appetite—reducing food intake by up to 50 per cent within an hour—and triggered fat-loss without any of the common side-effects associated with GLP1 drugs, such as nausea, digestive distress or muscle wasting. But its final efficacy will only come to light with human clinical studies and regulatory approvals.But do they work as claimed? The evidence is thin. Experts caution that while supplements may support bloodsugar health modestly, they do not match the robust clinical results of GLP1 drugs. Weight-loss with supplements typically amounts to just onetofour pounds—compared to the doubledigit percentages achieved by prescription treatments. And because dietary supplements are less regulated, quality and safety vary widely. Some supplement lines position themselves as companions for GLP1 users—through a range of shakes and fibres to support those losing appetite and muscle mass on the medication itself. There is no harm in taking these alongside a prescribed medicine, say experts.advertisementDespite the lack of clinical proof, many like Rao continue to long for an easy, natural fix, but also fear complacency. In the end, Rao says she resolved to consult her physician, knowing that progress—not placebo—might require interventions that were clinical, not just cosmetic.In India's rapidly shifting diabetes landscape, the allure of natural GLP1 alternatives is powerful, but careful awareness is essential. For all the pasteldraped promises, only proven therapies may offer more than hope.Subscribe to India Today Magazine- Ends
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

State approves ₹200 crore bridge project between Kotepura and Bolar, says Dinesh Gundu Rao
State approves ₹200 crore bridge project between Kotepura and Bolar, says Dinesh Gundu Rao

The Hindu

time3 hours ago

  • The Hindu

State approves ₹200 crore bridge project between Kotepura and Bolar, says Dinesh Gundu Rao

The State government has approved construction of a bridge between Kotepura (in Ullal) and Bolar at a cost of ₹200 crore, Dakshina Kannada district in charge Minister Dinesh Gundu Rao said in Mangaluru on Friday. In his Independence day address at the Nehru Maidan, Mr. Rao said the government has also approved construction of a new bridge, across the Netravati, between Sajipanadu in Bantwal taluk and Thumbe at a cost of ₹60 crore. These two bridges will not just ease traffic movement but also aid further development of the region, he said. The Minister said the PWD has taken up widening of Guruvayanakere-Uppinangady-Puttur stretch of the State highway. Road widening, construction of bridges and other works have been taken up on the Subrahmanya-Manjeshwar, Kadur-Kanhangad and Surathkal-Kabaka roads. A bridge was being re-constructed across Darpana river on the State highway in Kadaba taluk at a cost of ₹4.5 crore. The Addoor-Polali bridge was being repaired at a cost of ₹6.1 crore, the Ashwathapura-Mijar bridge was being constructed at a cost of ₹9 crore, and ₹4.95 crore was being spent for constructing a bridge on Parari-Ulaibettu-Mallur main raod. Seven new Indira canteens have been sanctioned, in addition to 17 Indira canteens in the district. The government is building G+3 apartment at Idya, near Surathkal, for 792 houseless persons. The Shakti, Gruha Jyothi, Gruha Lakshimi, and Yuva Nidhi guarantee schemes were doing well in the district, he said. As many as 33,356 people from Dakshina Kannada took the benefit of Puneet Rajkumar Hrudaya Jyoti scheme between March 2024 and July 2025. Under the scheme, district and taluk hospitals act as hubs where ECGs are done, while ECGs are analysed and necessary surgeries, if needed, are performed at Yenepoya Hospital at Deralakatte. A total of 296 people have undergone cardiac related surgery under the scheme, the Minister said. As many as 16 district hospitals in the State, including Government Wenlock Hospital, has Day Care Chemotherapy facility. Gruha Arogya scheme was being effectively implemented in the the district under which house-to-house visits were being done to make people aware about 14 communicable diseases and necessary medicine kits were being given, Mr. Rao said. Affirming commitment of the State government to ensure peace and tranquility in Dakshina Kannnada, the Minister said the government will not be bogged down by any external pressure in ensuring peace in the region. Mr. Rao said religious leaders were being told to make their people aware about importance of communal amity. Yakshagana troupes will also be involved in spreading message of communal harmony, he added.

Seeds of doubt: Why India's chia, pumpkin and flax obsession needs a hard look
Seeds of doubt: Why India's chia, pumpkin and flax obsession needs a hard look

India Today

time10 hours ago

  • India Today

Seeds of doubt: Why India's chia, pumpkin and flax obsession needs a hard look

Walk into a trendy caf in Delhi or Gurgaon today, and you'll find this tucked somewhere on the menu: a 'superfood bowl' with chia pudding, flax granola, and a scattering of pumpkin seeds. These items are priced at anything between Rs 450 and Rs 600. The jars have travelled from Instagram grids to kitchen shelves, marketed as "passports to better health".advertisementTruly a seductive comes with its omega-3s and antioxidants like quercetin, pumpkin seeds with zinc and magnesium for immunity, flax with lignans for heart health. Put together, they sound like nature's miracle cure but scratch beneath the marketing gloss, and the scientific verdict is far less glamorous. A meta-analysis of randomised controlled trials on chia found no significant change in cholesterol or blood sugar levels. There were modest reductions in waist circumference and systolic blood pressure. Useful, yes, but far from the miracle claims. Similar caution applies to pumpkin and flax: small, specific benefits, not sweeping Mehta, a senior dietician from Narayana Superspeciality Hospital, puts it across clearly. 'Seeds are nutritious, but overconsumption can risk choking or high-calorie intake.'And yet, the marketing machine thrives. As one nutrition-savvy Redditor wrote, with more accuracy than irony: 'A lot of these one-ingredient panaceas are pseudoscience. Just enough science to make it seem legit.'SIDE-EFFECTS NOBODY PUTS ON A WELLNESS POSTERSeeds are nutrient-dense, but they come with footnotes, the kind rarely mentioned in influencer videos. For instance, chia's water-swelling properties, which marketers celebrate, can be dangerous if eaten dry, leading to choking or even esophageal blockage. Pumpkin and flax, high in oxalates, can aggravate kidney stone risk. Dr. Saurabh Mongia, a Harvard- and Stanford-trained gastroenterologist, puts it sharply - 'Never eat chia seeds dry. Soak them for at least 30 minutes, ideally overnight.'The seeds are high-fibre, which can trigger bloating, gas, and IBS flare-ups. Omega-3-rich seeds can also interfere with blood thinners, while lignans in flax may affect hormone-sensitive conditions. Dr. Anita Jatana, chief dietician at Indraprastha Apollo Hospital, is blunt as she maintains, 'Medication interactions, hormonal sensitivities, kidney stone risk — seeds may not suit everyone.'PANTRY STAPLE OR SOCIAL CURRENCYIn urban India, seeds have morphed from being foods to social signals. The mason jar of chia in your kitchen is no longer just a pantry item; it's proof that you're 'wellness-aware.'The elevation of seeds to near-mythical status mirrors the global superfood marketing ploy, which is to extract a single ingredient from its natural dietary context, give it an exotic story, and promise sweeping health fixes. It's a formula that sells especially to an aspirational middle class seeking quick health doctors have warned that a teaspoon of chia won't undo years of sedentary living (the same applies for pumpkin and flax too!).BRING INDIA TO THE DINING TABLEIndia's own food heritage offers what global wellness trends often try to recreate. The National Institute of Nutrition (ICMR–NIN) has repeatedly affirmed that a diverse, predominantly plant-based diet with millets, pulses, seasonal vegetables, fresh fruit, nuts, and traditional oils remains one of the most balanced in the dals are known to deliver plant protein and fibre without the choking hazard and our leafy greens and jaggery bring minerals without a boutique-esque price tag. Mustard and groundnut oils provide healthy fats without Instagram hashtags. Dr Jatana agrees. She says, "The healthiest Indian thali isn't the one loaded with imported 'superfoods' but the one that's balanced, seasonal, and diverse.'The verdict? Chia, pumpkin, and flax are fine additions to a balanced diet taken in small, soaked, sensible amounts. But they're not your shortcut to health, and treating them as such is like expecting a garnish to replace the meal.- Ends

‘Must take proactive steps'—PM Modi reiterates concern over obesity crisis in I-Day address
‘Must take proactive steps'—PM Modi reiterates concern over obesity crisis in I-Day address

The Print

time11 hours ago

  • The Print

‘Must take proactive steps'—PM Modi reiterates concern over obesity crisis in I-Day address

Modi reinforced his previous recommendations to address this, urging families to purchase 10 percent less cooking oil, and reduce its consumption by the same margin on a regular basis. 'When discussing fitness, I am compelled to raise an important concern. Obesity is becoming a significant challenge that every family should take seriously. We must take proactive steps to protect ourselves from it,' the prime minister said. New Delhi: Prime Minister Narendra Modi has once again raised concerns about the issue of obesity, stressing on the need for collective action to tackle the crisis. In his address at Red Fort in Delhi on the occasion of the 79th Independence Day, Modi highlighted expert forecasts indicating that one in every three individuals in the country could become obese in near future. A 2023 survey by the Indian Council of Medical Research (ICMR) and Madras Diabetes Research Foundation (MDRF) had shown that 25.4 crore Indians or 28.6 percent of the population had generalised obesity. This survey had estimated the number of people with abdominal obesity at 351 million, or 39.5 percent of the population. The ICMR-National Institute of Nutrition, in its dietary guidelines last year, had noted that there is rising prevalence of overweight and obesity in several states, adding that 56.4 percent of India's total disease burden is due to unhealthy diets with a major focus on carbohydrates. Obesity, now recognised as a chronic, relapsing disease, is a major risk factor for diabetes, and is found to be linked to over 200 health complications, including hypertension, dyslipidemia or high blood cholesterol, coronary heart disease, some types of cancers and obstructive sleep apnea, among others. The World Health Organization (WHO) defines overweight and obesity in adults using body mass index. Those with a BMI between 25 and 30 kilograms per square metre are considered overweight, while people with a BMI of more than 30 kilograms per square metre are classified as obese. However, according to experts, India has a larger problem of abdominal obesity, characterised by fat deposition around crucial internal organs, but comparatively thinner limbs, which throws its own set of challenges. The growing obesity crisis has prompted Modi, on several occasions this year, to make a pitch for efforts to curb the epidemic. In his monthly radio broadcast in February, he had first called on people to reduce the use of cooking oils commonly found in unhealthy food. He had also previously urged people to adopt an active and healthy lifestyle in order to prevent obesity. This year, India saw the launch of two drugs—Wegovy by Novo Nordisk and Mounjaro by Eli Lilly and Company—that have been global smash hits for years for obesity treatment exclusively. (Edited by Mannat Chugh) Also Read: 82.5 mn Indians were 'obese' in 2022, shows Lancet study. Doctors, nutritionists say 'tip of iceberg'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store